Mannheimia haemolytica (Newsom and Cross) Angen et al.拉丁名
(ATCC? 55518?) 統(tǒng)一編號(hào)
Deposited As Pasteurella haemolytica Newsom and Cross
Strain Designations 別名 NADC-D60aroA-
Application Used to produce live, attenuated veterinary vaccines against Pasteurella haemolytica
Isolation 用途 Lung from cow with pneumonic pasteurellosis
Biosafety Level 生物安全等級(jí) 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Storage Conditions 保藏條件 Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol? no
Type Strain 模式菌種 no
Medium 培養(yǎng)基 ATCC? Medium 44: Brain Heart Infusion Agar/Broth
ATCC?
Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions 生長(zhǎng)條件
Temperature 培養(yǎng)溫度 : 37°C
Atmosphere 需氧條件: Aerobic
Name of Depositor 寄存者 National Animal Disease Center, ARS, USDA
U.S. Patent Number 5,587,305
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Special Collection NCRR Contract
References 參考文獻(xiàn) Briggs RE, Tatum FM. Construction of Pasteurella haemolytica vaccines. US Patent 5,733,780 dated Mar 31 1998